Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Mar 10, 2026
Episode
354
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guest Dr. Sam Rosner examine controversies around antibody-drug conjugates (ADCs) live from the 2026 Targeted Therapies of Lung Cancer (TTLC) conference.
Guest
Sam Rosner
MD
Assistant Professor of Medicine
Thoracic Medical Oncologist
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
